Breakpoint Therapeutics is a startup based in Germany.
Breakpoint Therapeutics is a company headquartered in Germany.
Breakpoint Therapeutics GmbH is a biotechnology company that discovers and develops small-molecule cancer therapies targeting DNA damage response (DDR) pathways. Its pipeline includes preclinical programs such as polymerase theta (POLQ) inhibitors aimed at treating oncology indications.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.